Integer Holdings Price Target Maintained With a $130.00/Share by Benchmark
Integer Holdings Analyst Ratings
Benchmark Reiterates Buy on Integer Holdings, Maintains $130 Price Target
Benchmark Co. Maintains Integer Holdings(ITGR.US) With Buy Rating, Maintains Target Price $130
Truist Financial Maintains Integer Holdings(ITGR.US) With Buy Rating
Oppenheimer Maintains Integer Holdings(ITGR.US) With Buy Rating, Maintains Target Price $135
KeyBanc Maintains Integer Holdings(ITGR.US) With Buy Rating, Maintains Target Price $139
Analysts Offer Insights on Healthcare Companies: Integer Holdings (ITGR), Universal Health (UHS) and Sanofi (OtherSNYNF)
Integer Holdings Analyst Ratings
Integer Holdings Analyst Ratings
Integer Holdings Analyst Ratings
Integer Holdings Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Intellia Therapeutics (NTLA), Integer Holdings (ITGR) and ACADIA Pharmaceuticals (ACAD)
Integer Holdings Analyst Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: Integer Holdings (ITGR), Resmed (RMD) and PTC Therapeutics (PTCT)
Integer Holdings Analyst Ratings
KeyBanc Raises Price Target on Integer Holdings to $139 From $123, Keeps Overweight Rating
Integer Holdings Analyst Ratings
Integer Holdings Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Integer Holdings (ITGR), Akebia Therapeutics (AKBA) and Moderna (MRNA)
No Data
No Data